Pharmaceutical ingredients, including EPA and DHA production, adding to Japanese seafood giants' bottom lines
Pharmaceutical ingredients, such as omega-3s, chondroitin, squalene, and more, are increasingly becoming a source of revenue for Japan's seafood companies.